Search results
TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer's Disease
Financial Post· 7 days agoAuthorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages of
Animals self-medicate with plants − behavior people have observed and emulated for millennia
The Conversation via Yahoo Canada News· 3 days agoThis article is republished from The Conversation, a nonprofit, independent news organization...